Back
Informatica 10K Form
Sell
29
INFA
Informatica
Last Price:
25.28
Seasonality Move:
14.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | INFA/Informatica Quarterly |
2023-11-02 | 10Q | INFA/Informatica Quarterly |
2023-08-03 | 10Q | INFA/Informatica Quarterly |
2023-05-04 | 10Q | INFA/Informatica Quarterly |
2022-11-10 | 10Q | INFA/Informatica Quarterly |
2022-08-04 | 10Q | INFA/Informatica Quarterly |
Receive INFA News And Ratings
See the #1 stock for the next 7 days that we like better than INFA
INFA Financial Statistics
Sales & Book Value
Annual Sales: | $1.6B |
---|---|
Cash Flow: | $105.73M |
Price / Cash Flow: | 21.77 |
Annual Sales: | $7.89 |
Price / Book: | 3.25 |
Profitability
EPS (TTM): | 0.21000 |
---|---|
Net Income (TTM): | $64.44M |
Gross Margin: | $1.26B |
Return on Equity: | 2.86% |
Return on Assets: | 1.27% |
Informatica Earnings Forecast
Key Informatica Financial Ratios
- The Gross Profit Margin over the past 16 years for INFA is 78.79%.
- The Selling, General & Administrative Expenses for INFA have been equal to 43.32% of Gross Profit Margin.
- The Research & Development expenses have been 21.01% of Revenue.
- The Interest Expense is -120.84% of Operating Income.
- The Net Earning history of INFA is -7.85% of Total Revenues.
- Per Share Earnings over the last 16 years have been positive in 10 years.
Informatica Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | INFA |
CUSIP: | 45666Q |
Website: | informatica.com |
Debt
Debt-to-Equity Ratio: | 0.75 |
---|---|
Current Ratio: | 2.17 |
Quick Ratio: | 1.89 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 21.03 |
INFA Technical Analysis vs Fundamental Analysis
Sell
29
Informatica (INFA)
is a Sell
Is Informatica a Buy or a Sell?
-
Informatica stock is rated a Sell
The current Informatica [INFA] share price is $25.61. The Score for INFA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.